Foresite Capital Management V, LLC — SEC Form 4 filings
SEC reporting owner CIK 1792206. 9 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-04-05 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 7 filings — 3,732,405 shares, $54,349,928 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 79.
- Largest priced transaction: purchase of 2,187,500 shares @ $16.00 ($35,000,000) in ALUMIS INC., filed 2024-07-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALUMIS INC. (ALMS) | 10% owner | 6 | 11 legs · 3,536,850 sh · $50,829,938 | — | 34 |
| Latigo Biotherapeutics, Inc. (LTGO) | 10% owner | 1 | 1 leg · 140,000 sh · $2,520,000 | — | 14 |
| Eikon Therapeutics, Inc. (EIKN) | 10% owner | 1 | 1 leg · 55,555 sh · $999,990 | — | 28 |
| Kinnate Biopharma Inc. (KNTE) | 10% owner | 1 | — | — | 3 |
Form 4 filings — Foresite Capital Management V, LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Latigo Biotherapeutics, Inc. (LTGO) jointly with Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP | Conversion (C): 3,117,664 @ $0 · Conversion (C): 445,320 @ $0 · Conversion (C): 1,125,823 @ $0 · Conversion (C): 742,201 @ $0 · Purchase (P): 140,000 @ $18 · Conversion (C): 195,776 · +9 more | EDGAR |
| 2026-04-03 | 4 | ALUMIS INC. (ALMS) jointly with Foresite Capital Management VI LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Fund VI LP, Labs Co-Invest V, LLC, Foresite Labs Management I, LLC, Foresite Labs Fund I, L.P. | Other (J): 1,176,470 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 1,123,337 @ $0 · Other (J): 680,486 @ $0 | EDGAR |
| 2026-02-06 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Foresite Capital Management IV, LLC, Foresite Capital Fund IV, L.P., Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital VI-A Management, LLC, Foresite Capital VI-A, LLC | Conversion (C): 1,340,878 @ $0 · Conversion (C): 335,521 @ $0 · Conversion (C): 37,855 @ $0 · Conversion (C): 229,428 @ $0 · Conversion (C): 697,885 @ $0 · Conversion (C): 37,855 @ $0 · +23 more | EDGAR |
| 2026-01-12 | 4 | ALUMIS INC. (ALMS) jointly with Foresite Capital Management VI LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Fund VI LP, Labs Co-Invest V, LLC, Foresite Labs Management I, LLC, Foresite Labs Fund I, L.P. | Purchase (P): 117,647 @ $17 · Purchase (P): 294,117 @ $17 | EDGAR |
| 2025-11-25 | 4 | ALUMIS INC. (ALMS) jointly with Foresite Capital Management VI LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Fund VI LP, Labs Co-Invest V, LLC, Foresite Labs Management I, LLC, Foresite Labs Fund I, L.P. | Purchase (P): 72,212 @ $7.38 | EDGAR |
| 2025-11-19 | 4 | ALUMIS INC. (ALMS) jointly with Foresite Capital Management VI LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Fund VI LP, Labs Co-Invest V, LLC, Foresite Labs Management I, LLC, Foresite Labs Fund I, L.P. | Purchase (P): 50,000 @ $5.60 · Purchase (P): 150,000 @ $5.59 · Purchase (P): 117,374 @ $6.19 · Purchase (P): 190,500 @ $6.56 | EDGAR |
| 2025-05-06 | 4 | ALUMIS INC. (ALMS) jointly with Foresite Capital Management VI LLC, Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Fund VI LP, Labs Co-Invest V, LLC, Foresite Labs Management I, LLC, Foresite Labs Fund I, L.P. | Purchase (P): 25,000 @ $4.62 · Purchase (P): 20,000 @ $4.34 | EDGAR |
| 2024-07-03 | 4 | ALUMIS INC. (ALMS) jointly with Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Management VI LLC, Foresite Capital Fund VI LP, Labs Co-Invest V, LLC, Foresite Labs Management I, LLC, Foresite Labs Fund I, L.P. | Conversion (C): 1,944,577 @ $0 · Conversion (C): 1,122,994 @ $0 · Conversion (C): 560,076 @ $0 · Conversion (C): 622,344 @ $0 · Conversion (C): 1,022,398 @ $0 · Purchase (P): 312,500 @ $16 · +26 more | EDGAR |
| 2024-04-05 | 4 | Kinnate Biopharma Inc. (KNTE) jointly with Foresite Capital Management IV, LLC, Foresite Capital Fund IV, L.P., Foresite Capital Fund V, L.P., Foresite Capital Opportunity Management V, LLC, Foresite Capital Opportunity Fund V, L.P. | Disposition to issuer (D): 9,671,643 · Disposition to issuer (D): 3,525,957 · Disposition to issuer (D): 520,711 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1792206 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →